Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Reynolds

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Neuroscience Letters|July 25, 2013
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai populationRachanee Chanasong, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|December 15, 2016
Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosisSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
European Journal of Pharmacology|November 24, 2004
Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the ratShona L Kirk, Joanna C Neill, Declan N C Jones, et al.
Pharmacogenomics|September 25, 2015
BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Psychiatric Genetics|September 10, 2003
Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesiaZhi Jun Zhang, Xiao Bin Zhang, Gang Hou, et al.
Psychopharmacology|August 19, 2009
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptorsShona L Kirk, John Glazebrook, Ben Grayson, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in RatsGavin P Reynolds, Caroline F Dalton, William Watrimez, et al.
The International Journal of Neuropsychopharmacology|August 14, 2016
TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant DrugsZhi Xu, Gavin P Reynolds, Yonggui Yuan, et al.
Neuroscience Letters|June 17, 2024
Regional-specific changes in rat brain BDNF in a model of methamphetamine abuseSri-Arun Iamjan, Siriluk Veerasakul, Gavin P Reynolds, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Neuroscience Letters|July 25, 2013
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai populationRachanee Chanasong, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|December 15, 2016
Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosisSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
European Journal of Pharmacology|November 24, 2004
Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the ratShona L Kirk, Joanna C Neill, Declan N C Jones, et al.
Pharmacogenomics|September 25, 2015
BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Psychiatric Genetics|September 10, 2003
Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesiaZhi Jun Zhang, Xiao Bin Zhang, Gang Hou, et al.
Psychopharmacology|August 19, 2009
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptorsShona L Kirk, John Glazebrook, Ben Grayson, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in RatsGavin P Reynolds, Caroline F Dalton, William Watrimez, et al.
The International Journal of Neuropsychopharmacology|August 14, 2016
TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant DrugsZhi Xu, Gavin P Reynolds, Yonggui Yuan, et al.
Neuroscience Letters|June 17, 2024
Regional-specific changes in rat brain BDNF in a model of methamphetamine abuseSri-Arun Iamjan, Siriluk Veerasakul, Gavin P Reynolds, et al.
Pageof 14